Erratum: HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia (Stem Cells (2014) 32 (231-243) DOI 10.1002/stem.1540)

Wang Yin; Celine Loinard; Wineke Bakker; Coralie L. Guerin; Jose Vilar; Clement DAudigier; Laetitia Mauge; Patrick Bruneval; Joseph Emmerich; Bernard I. Levy; Jacques Pouyssegur; David M. Smadja; Jean Sebastien Silvestre

doi:10.1002/stem.1652

Erratum: HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia (Stem Cells (2014) 32 (231-243) DOI 10.1002/stem.1540)

Wang Yin
, Celine Loinard
, Wineke Bakker
, Coralie L. Guerin
, Jose Vilar
, Clement DAudigier
, Laetitia Mauge
, Patrick Bruneval
, Joseph Emmerich
, Bernard I. Levy
, Jacques Pouyssegur
, David M. Smadja
, Jean Sebastien Silvestre

Research output: Contribution to journal › Correction

Original language	English
Pages (from-to)	1056
Number of pages	1
Journal	Stem Cells
Volume	32
Issue number	4
DOIs	https://doi.org/10.1002/stem.1652
Publication status	Published - Apr 2014

Access to Document

10.1002/stem.1652

Cite this

Yin, W., Loinard, C., Bakker, W., Guerin, C. L., Vilar, J., DAudigier, C., Mauge, L., Bruneval, P., Emmerich, J., Levy, B. I., Pouyssegur, J., Smadja, D. M., & Silvestre, J. S. (2014). Erratum: HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia (Stem Cells (2014) 32 (231-243) DOI 10.1002/stem.1540). Stem Cells, 32(4), 1056. https://doi.org/10.1002/stem.1652

@article{2943120494ef461381940c6373c51f03,

title = "Erratum: HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia (Stem Cells (2014) 32 (231-243) DOI 10.1002/stem.1540)",

author = "Wang Yin and Celine Loinard and Wineke Bakker and Guerin, \{Coralie L.\} and Jose Vilar and Clement DAudigier and Laetitia Mauge and Patrick Bruneval and Joseph Emmerich and Levy, \{Bernard I.\} and Jacques Pouyssegur and Smadja, \{David M.\} and Silvestre, \{Jean Sebastien\}",

year = "2014",

month = apr,

doi = "10.1002/stem.1652",

language = "English",

volume = "32",

pages = "1056",

journal = "Stem Cells",

issn = "1066-5099",

publisher = "Oxford University Press",

number = "4",

}

Yin, W, Loinard, C, Bakker, W, Guerin, CL, Vilar, J, DAudigier, C, Mauge, L, Bruneval, P, Emmerich, J, Levy, BI, Pouyssegur, J, Smadja, DM & Silvestre, JS 2014, 'Erratum: HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia (Stem Cells (2014) 32 (231-243) DOI 10.1002/stem.1540)', Stem Cells, vol. 32, no. 4, pp. 1056. https://doi.org/10.1002/stem.1652

TY - JOUR

T1 - Erratum

T2 - HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia (Stem Cells (2014) 32 (231-243) DOI 10.1002/stem.1540)

AU - Yin, Wang

AU - Loinard, Celine

AU - Bakker, Wineke

AU - Guerin, Coralie L.

AU - Vilar, Jose

AU - DAudigier, Clement

AU - Mauge, Laetitia

AU - Bruneval, Patrick

AU - Emmerich, Joseph

AU - Levy, Bernard I.

AU - Pouyssegur, Jacques

AU - Smadja, David M.

AU - Silvestre, Jean Sebastien

PY - 2014/4

Y1 - 2014/4

UR - https://www.scopus.com/pages/publications/84896340871

U2 - 10.1002/stem.1652

DO - 10.1002/stem.1652

M3 - Correction

AN - SCOPUS:84896340871

SN - 1066-5099

VL - 32

SP - 1056

JO - Stem Cells

JF - Stem Cells

IS - 4

ER -

Erratum: HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia (Stem Cells (2014) 32 (231-243) DOI 10.1002/stem.1540)

Access to Document

Other files and links

Cite this